Q4 2024 Management View Anders Danielsson, President and CEO, highlighted strong Q4 results, emphasizing a record-high order backlog of SEK 285 billion, driven by robust order bookings with a ...
Medpace demonstrates strong financial performance and growth in the CRO market, despite facing challenges in the short term. Read why MEDP stock is a Strong Buy.
Q4 2024 Management View CEO Luis Felipe Castellanos highlighted the recovery in Peru’s macroeconomic environment, with GDP growth in Q4 reaching 3.7% and expectations for 2.8% growth in 2025. He ...
Kyle Peterson has given his Buy rating due to a combination of factors surrounding Axos Financial’s strong financial performance and ... a Buy rating and increase the price target to $88.